2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Vascular Dysfunction That is Dependent on Perivascular Adipose and Cytochrome P4501A1 Expression

May 23, 2019Cardiovascular toxicology

Vascular problems caused by 2,3,7,8-Tetrachlorodibenzo-p-dioxin depend on fat around blood vessels and a specific enzyme

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

TCDD significantly enhanced vasoconstriction and inhibited vasorelaxation in aorta with perivascular adipose tissue (PVAT).

Cyp1a1 mRNA levels were increased in the aorta of wild-type mice with PVAT and remained elevated until day 14.
TCDD exposure led to greater constriction in response to a thromboxane mimetic in wild-type mice, but this effect was absent in Cyp1a1 knockout mice.
The presence of PVAT was necessary for TCDD to inhibit relaxation responses to acetylcholine and a nitric oxide donor.
TCDD exposure induced the expression of angiotensinogen and phosphodiesterase 5a in the aorta with PVAT, which may contribute to vascular dysfunction.
These findings suggest that PVAT and Cyp1a1 play critical roles in TCDD-induced vascular dysfunction.

AI simplified

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is associated with hypertension in humans and animals, and studies suggest that cytochrome P4501A1 (Cyp1a1) induction and vascular dysfunction may contribute. We investigated the role of perivascular adipose tissue (PVAT) and Cyp1a1 in TCDD-induced vascular dysfunction. Cyp1a1 wild-type (WT) and knockout (KO) male mice were fed a dough pill containing 1,4-p-dioxane (TCDD vehicle control) on days 0 and 7, or 1000 ng/kg TCDD on day 0 and 250 ng/kg TCDD on day 7. mRNA expression of Cyp1a1 was assessed on days 3, 7, and 14, and of Cyp1b1, 1a2, angiotensinogen, and phosphodiesterase 5a on day 14. Dose-dependent vasoconstriction to a thromboxane Amimetic (U46619), and vasorelaxation to acetylcholine and a nitric oxide donor (S-nitroso-N-acetyl-DL-penicillamine, SNAP), were investigated in the aorta with and without PVAT. Cyp1a1 and 1a2 mRNA was induced in aorta of WT mice only with PVAT, and Cyp1a1 induction was sustained through day 14. TCDD significantly enhanced constriction to U46619 in WT mice and inhibited relaxation to both acetylcholine and SNAP, but only in the presence of PVAT. The effects of TCDD on U46619 constriction and SNAP relaxation were not observed in Cyp1a1 KO mice. Finally, in aorta + PVAT of WT mice TCDD significantly induced expression of angiotensinogen and phosphodiesterase 5a both of which could contribute to the TCDD-induced vascular dysfunction. These data establish PVAT as a TCDD target which is critically involved in mediating vascular dysfunction. TCDD enhances vasoconstriction via the thromboxane/prostanoid (TP) receptor and inhibits vasorelaxation via nitric oxide (NO) signaling. This TCDD-induced vascular dysfunction requires perivascular adipose (PVAT) and cytochrome P4501a1 (CYP1a1) induction. 2

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Vascular Dysfunction That is Dependent on Perivascular Adipose and Cytochrome P4501A1 Expression

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief